TP53 and lung carcinoma: We also observed that the levels of p-ERK1/2 were reduced by the knockdown of RPIA in two other lung cancer cell lines: H23 lung cancer cells (p53M246I and KRASG12C) and H358 lung cancer cells (p53-null and KRASG12C) (Figure S2).